Advanced Bioanalytical Technology Portfolio

United Pharmaceuticals maintains a comprehensive suite of bioanalytical platforms designed to support both small- and large-molecule programs with speed, accuracy, and scalability. Our integrated technologies enable efficient study execution while delivering high-quality, defensible data across discovery, preclinical, and clinical development.

By combining advanced instrumentation with automated workflows and experienced scientific oversight, we ensure that each platform is applied strategically to meet the scientific and regulatory demands of your program.

Purpose-Built Laboratories for Complex Bioanalysis

Our bioanalytical laboratories are strategically equipped to support a broad range of regulated and non-regulated studies. Each facility is designed to handle diverse assay types, complex biological matrices, and high sample volumes while maintaining consistency, traceability, and data integrity.

Across our global laboratory network, we support assay development, validation, and routine sample analysis using modern, scalable technologies aligned with GxP expectations.

Comprehensive Platform Capabilities

United Pharmaceuticals’ bioanalytical infrastructure includes a wide range of advanced platforms and supporting technologies, enabling us to tailor solutions to your specific study objectives:

• High-resolution mass spectrometry systems supporting quantitative and qualitative analysis
• Liquid chromatography platforms for robust separation and method flexibility
• Automated extraction workflows for large-molecule bioanalysis, improving reproducibility and throughput
• High-throughput automation for efficient handling of large sample sets
• Detection technologies supporting absorbance, fluorescence, and luminescence assays
• Multiplexing platforms enabling simultaneous analysis of multiple analytes
• Automated sample handlers and tissue homogenization systems for complex matrices

This integrated technology ecosystem allows us to support diverse therapeutic modalities, from traditional small molecules to biologics, oligonucleotides, and advanced therapies.

Platform Selection Guided by Scientific Strategy

Selecting the right bioanalytical platform is critical to generating meaningful and reliable data. Our scientists work closely with sponsors to evaluate assay requirements, sensitivity needs, matrix complexity, throughput demands, and regulatory considerations before recommending the most appropriate platform.

This consultative approach ensures that each study is supported by the right technology—maximizing efficiency while minimizing risk throughout development.

Enabling Confident Decisions Through Quality Data

United Pharmaceuticals’ bioanalytical platforms are more than instruments—they are part of a fully integrated scientific and quality framework designed to support informed decision-making. From early feasibility studies to late-stage clinical programs, our technologies and expertise work together to accelerate timelines and strengthen confidence in your data.